ArticleBiomolecules & biomedicine2024

Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.

Hua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.